You are viewing an incomplete version of our website. Please click to reload the website as full version.

BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13) (Internal Region) Peptide

Details for Product No. ABIN1382115, Supplier: Log in to see
Protein Name
  • BCL-RAMBO
  • Bcl2-L-13
  • E430016C20Rik
  • Mil-1
  • MIL1
  • Mil1
  • si:ch211-238n5.7
Protein Region
Internal Region
Origin
Human
1
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-BCL2L13 antibody (BCL2-Like 13 (Apoptosis Facilitator)) (Middle Region) (ABIN1030885)
Characteristics 15 amino acids near the center of human Bcl-rambo
Human
Application Notes Bcl-rambo peptide is used for blocking the activity of the Bcl-rambo.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Kataoka, Holler, Micheau, Martinon, Tinel, Hofmann, Tschopp: "Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension." in: The Journal of biological chemistry, Vol. 276, Issue 22, pp. 19548-54, 2001 (PubMed).

Hugot, Chamaillard, Zouali, Lesage, Cézard, Belaiche, Almer, Tysk, OMorain, Gassull, Binder, Finkel, Cortot, Modigliani, Laurent-Puig, Gower-Rousseau, Macry, Colombel, Sahbatou, Thomas: "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 599-603, 2001 (PubMed).

Ogura, Bonen, Inohara, Nicolae, Chen, Ramos, Britton, Moran, Karaliuskas, Duerr, Achkar, Brant, Bayless, Kirschner, Hanauer, Nuñez, Cho: "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 603-6, 2001 (PubMed).